Ondas stock rises on acquisition of UK defense tech firm Rotron Aero

Investing.com -- Plumas Bancorp (NASDAQ:PLBC) stock rose 3.6% on Monday after the parent company of Plumas Bank announced a new $25 million share repurchase program.

The buyback authorization, which runs through the fourth quarter of 2026, allows the company to repurchase shares through open market purchases, privately negotiated transactions, or block trades, depending on market conditions and other factors.

Plumas plans to fund the repurchases using available cash and retained earnings. The company noted that the program may be suspended, modified, or discontinued at any time at its discretion.

"This repurchase program reflects our strong capital position, commitment to disciplined capital management and our confidence in the long-term outlook for the Company," said Andrew J. Ryback, President and Chief Executive Officer of Plumas Bancorp.

The announcement signals management’s confidence in the company’s financial health and future prospects. Share repurchase programs typically benefit investors by reducing the number of outstanding shares, which can increase earnings per share and potentially drive stock price appreciation over time.

Plumas Bancorp did not specify a target number of shares to be repurchased under the program, noting that the actual timing, number, and value of shares repurchased will depend on various factors including market conditions and capital availability.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Investing.com -- CorMedix Inc (NASDAQ:CRMD) stock rose 5.7% on Monday after the biopharmaceutical company announced a $75 million share repurchase program.

The company’s board of directors has authorized the buyback of up to $75 million of its outstanding common stock through December 31, 2027. CorMedix expects to begin repurchasing shares as early as the first quarter of 2026.

"With a strong balance sheet, solid operating performance, and expected ongoing cash flow generation, we believe we are well positioned to execute this share repurchase program while continuing to advance our growth strategy," said Joseph Todisco, Chairman & CEO of CorMedix Therapeutics.

The company, which focuses on developing therapeutic products for life-threatening diseases and conditions, reported approximately $150 million in cash and cash equivalents as of December 31, 2025. CorMedix had 79.3 million common shares outstanding at that time.

The repurchase program allows for buybacks through privately negotiated transactions, block trades, open market purchases, or trading plans as permitted under securities laws. The company noted that the program does not require it to acquire any specific amount of shares and may be suspended or discontinued at any time.

Todisco added that the program provides a "disciplined way to return value to shareholders while preserving the financial flexibility to invest in our business, including potential inorganic opportunities."

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Investing.com -- Global Interactive Technologies, Inc. (NASDAQ:GITS) stock jumped 5.6% on Monday after the digital media company announced a partnership with K-pop star Kang Daniel for its upcoming animated feature film.

The company has secured definitive agreements with the popular artist to produce and perform official theme songs for "The Legend of MegaRace." Under the terms of the deal, GITS will own the master recordings and control worldwide distribution and usage rights for each song.

Kang Daniel, described by the company as a "powerhouse soloist with over 2 million albums sold," first gained international recognition as a member of the K-pop group Wanna One. The artist has previously appeared on Billboard’s World Digital Song Sales chart and holds a Guinness World Record.

GITS plans to distribute promotional materials related to the theme songs through Faning, its global fandom platform. The company emphasized that these agreements align with its strategy of maintaining strict music IP ownership and controlled distribution.

A company representative stated that by collaborating with a top-tier K-pop star, GITS is "taking a structured, long-term approach to building music assets that support scalable content commercialization."

The partnership adds to GITS’s previously announced artist collaborations as part of its broader strategy to expand proprietary intellectual property across animation-related music and content assets.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Investing.com -- SenesTech Inc (NASDAQ:SNES) stock rose 7% Monday after the company announced its Evolve fertility control solution for rodents has been approved for use in New Zealand by the Ministry for Primary Industries.

The Phoenix-based company, which specializes in fertility control solutions for managing rodent populations, has shipped an initial stocking order to its exclusive distribution partner Evicom. The approval positions SenesTech to support New Zealand’s Predator Free 2050 initiative, an ambitious conservation program aimed at eradicating invasive predators like rats to protect native species.

"We are delivering on our strategy to become the global leader in sustainable fertility control solutions for managing rat populations, while tapping into significant, high-growth markets that are actively seeking sustainable and effective alternatives to traditional rodenticides," said Joel Fruendt, President and CEO of SenesTech.

The company’s Evolve product offers a non-lethal alternative to traditional rodenticides, reducing rat populations by restricting reproduction rather than through poisoning. This approach aligns with New Zealand’s conservation goals, which focus on preserving biodiversity and protecting delicate ecosystems.

New Zealand expects to spend over $4.5 billion on its Predator Free 2050 program, creating a significant market opportunity for SenesTech’s fertility control technology. The company indicated it expects to maintain a regular shipping schedule with Evicom following the initial container shipment.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Investing.com -- Verra Mobility (NASDAQ:VRRM) stock fell 4% Monday after the Washington Post reported that the Trump administration is restricting cities from using federal road safety grants to purchase speed cameras.

The U.S. Department of Transportation has informed cities they will not be permitted to use safety dollars to subsidize the acquisition of speed cameras, according to a department spokesperson cited in the Washington Post report. The policy change could potentially impact Verra Mobility, which provides technology and services for traffic safety and toll collection.

In addition to the speed camera restrictions, the administration is also barring proposals to extend sidewalk curbs farther into roadways, with limited exceptions for areas such as transit stops and school zones, according to the report.

The new restrictions could affect Verra Mobility’s government solutions segment, which includes automated safety enforcement programs for municipalities and school districts. The company’s business model includes providing and maintaining speed and red-light cameras for local governments.

Verra Mobility operates across multiple segments including commercial services and government solutions, with the latter potentially facing headwinds from these new federal funding limitations.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

VeraDermics is said to draw IPO anchor order from Eli Lilly - Bloomberg